Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian R Untch

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Annals of Surgical Oncology|December 25, 2013
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinomaBrian R Untch, Frank L Palmer, Ian Ganly, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2010
Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidismMohamed Abdelgadir Adam, Brian R Untch, Melissa E Danko, et al.
Genes, Chromosomes & Cancer|February 16, 2022
FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumorJosephine K Dermawan, Chad M Vanderbilt, Jason C Chang, et al.
Journal of the American College of Surgeons|April 6, 2011
Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 yearsBrian R Untch, Mohamed Abdelgadir Adam, Randall P Scheri, et al.
Cancers|March 13, 2025
Clinical and Pathologic Characteristics of Cytologically Indeterminate Thyroid Nodules with Non-V600E <i>BRAF</i> AlterationsRyan Instrum, Christina E Swartzwelder, Ronald A Ghossein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine CarcinomasLaura H Tang, Brian R Untch, Diane L Reidy, et al.
Pancreas|October 21, 2016
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly DifferentiatedNitya Raj, Emily Valentino, Marinela Capanu, et al.
Thyroid : Official Journal of the American Thyroid Association|August 11, 2022
Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid CarcinomaAradhya Nigam, Bin Xu, Philip M Spanheimer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2020
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcomeBayan Alzumaili, Bin Xu, Philip M Spanheimer, et al.
Annals of Surgical Oncology|September 25, 2019
Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid CarcinomaPhilip M Spanheimer, Ian Ganly, Joanne Chou, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Annals of Surgical Oncology|December 25, 2013
Oncologic outcomes after completion thyroidectomy for patients with well-differentiated thyroid carcinomaBrian R Untch, Frank L Palmer, Ian Ganly, et al.
The Journal of Clinical Endocrinology and Metabolism|August 6, 2010
Severe obesity is associated with symptomatic presentation, higher parathyroid hormone levels, and increased gland weight in primary hyperparathyroidismMohamed Abdelgadir Adam, Brian R Untch, Melissa E Danko, et al.
Genes, Chromosomes & Cancer|February 16, 2022
FGFR2::TACC2 fusion as a novel KIT-independent mechanism of targeted therapy failure in a multidrug-resistant gastrointestinal stromal tumorJosephine K Dermawan, Chad M Vanderbilt, Jason C Chang, et al.
Journal of the American College of Surgeons|April 6, 2011
Surgeon-performed ultrasound is superior to 99Tc-sestamibi scanning to localize parathyroid adenomas in patients with primary hyperparathyroidism: results in 516 patients over 10 yearsBrian R Untch, Mohamed Abdelgadir Adam, Randall P Scheri, et al.
Cancers|March 13, 2025
Clinical and Pathologic Characteristics of Cytologically Indeterminate Thyroid Nodules with Non-V600E <i>BRAF</i> AlterationsRyan Instrum, Christina E Swartzwelder, Ronald A Ghossein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2015
Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine CarcinomasLaura H Tang, Brian R Untch, Diane L Reidy, et al.
Pancreas|October 21, 2016
Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly DifferentiatedNitya Raj, Emily Valentino, Marinela Capanu, et al.
Thyroid : Official Journal of the American Thyroid Association|August 11, 2022
Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid CarcinomaAradhya Nigam, Bin Xu, Philip M Spanheimer, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 22, 2020
Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcomeBayan Alzumaili, Bin Xu, Philip M Spanheimer, et al.
Annals of Surgical Oncology|September 25, 2019
Long-Term Oncologic Outcomes After Curative Resection of Familial Medullary Thyroid CarcinomaPhilip M Spanheimer, Ian Ganly, Joanne Chou, et al.
Pageof 5